Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-22-011983

CHIEF EXECUTIVE OFFICER sold 15,000 shares at $18.00 ($270,000)

  • CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-01 Exercise or conversion : show line 1 in the form +15,000 $2.14 $32,100 15,000 D
2022-12-01 Sale : show line 2 in the form −15,000 $18.00 $270,000 0 D
Open-market sales · 15,000 sh · avg $18.00 · $270,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-12-01 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −15,000 $2.14 2031-04-01 15,000 478,381 D
Loading xslF345X03/form4-12022022_071207.xml…